Loading...
13 Asia OB/GYN Drugs Reports
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, France, Germany, United Kingdom, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer, Teva Pharmaceutical Industries, Novartis, Takeda Pharmaceuticals, Bayer
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bayer, Novartis, Pfizer, Novo Nordisk, Abbvie
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Eli Lilly and Company, Roche, Merck, Abbvie
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Teva Pharmaceutical Industries, Bayer, Pfizer, Amneal Pharmaceuticals, Mayne Pharma
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea
Major Players: Eli Lilly and Company, GlaxoSmithKline, H. Lundbeck, MetP Pharma, Bayer
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bayer, Pfizer, Abbvie, Teva Pharmaceutical Industries, AstraZeneca
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer, Dr. Reddy’s Laboratories Ltd, Corcept Therapeutics Incorporated., GenBioPro, EVER Pharma
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Melinta Therapeutics, Merck, Pfizer, GlaxoSmithKline, Cipla
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Upsher-Smith Laboratories, Viatris, Zydus Group, Bayer, Stada Arzneimittel
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Gynesonics, Medtronic, INSIGHTEC, Myovant Sciences, Boston Scientific
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis, Bayer, Abbott Laboratories, Roche, Sanofi
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Ferring Pharmaceuticals, TherapeuticsMD, Abbvie, Pfizer, GlaxoSmithKline
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea
Major Players: Pfizer, Novartis, Eli Lilly and Company, Novo Nordisk, Lumos Pharma
Filter Reports
By Countries
